Tag: EYLEA
Regeneron secures updated label approval from FDA for EYLEA in wet-AMD
The US Food and Drug Administration (FDA) has approved a supplemental Biologics License Application (sBLA) by Regeneron Pharmaceuticals for EYLEA (aflibercept) Injection in patients with ... Read More